Don’t invest unless you’re prepared to lose all the money you invest. This is a high risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

EMVC Evergreen EIS Fund

The EMVC Evergreen EIS Fund invests in IP-rich, early-stage businesses across deep tech and life sciences which qualify for EIS tax relief.

Investors are able to access a diversified portfolio of high-growth companies, sourced from the wider EMV Capital PLC group portfolio and ecosystem. The fund benefits through co-investment with EMV Capital’s various pools of investment including Martlet Capital, its private practice and network of private and institutional investors.

Key InformationDetails
StructureEvergreen (open all year round)
Target portfolioUp to 8 companies per portfolio within 12 months (currently fully deploying within 6 months)
StageSeed / Series A
SectorsDeep Tech, Life Sciences, Sustainability
StrategyVenture Build + Co-invest
Minimum investment£25,000
Target Return3X Invested Capital
ManagerEMV Capital Partners Ltd
ParentEMV Capital plc (AIM: EMVC) — published accounts and regulatory filings available
Third-party reviewedYes
Also availableDeal-by-deal direct investment alongside the Fund
Third-Party Research

REVIEWED BY HARDMAN & CO TAX ADVANTAGED — September 2026

“EMV Capital has a solid investment process, a steady source of potential fund investments from EMVC’s existing portfolio of ca.70 companies and excellent industry relationships which can benefit companies.”

Brian Moretta, Hardman & Co — 9 September 2026

  • Unique dual strategy approach combining Venture Build and Co-investment
  • Specialist Deep Tech and Life Science focus
  • AIM-listed parent: Plc co-investment and enhanced governance & transparency
  • Deep access to Cambridge’s high-tech cluster and other UK regional research hubs
  • Proactive management of portfolio
  • Value creation within the Venture Build portfolio
  • Strong group track record
Hardman Report

Download Full Hardman Report

Hardman & Co • September 2026

Watch Podcast

Listen to the Podcast

EIS Navigator • Brian Moretta in conversation with Dr. Ilian Iliev

EMV Capital operates a unique, dual-channel investment approach:

Venture Build

  • The Venture Build programme consists of companies where EMV Capital takes major equity stakes.
  • These are companies where there exists strong, defensible IP and clear growth potential.
  • EMV Capital enters at an attractive initial valuation that reflects the significant value creation opportunity ahead.
  • EMV Capital works intensively alongside management to advance the companies to key commercial and technical milestones.
  • Companies are supported through EMV Capital’s Value Creation Services and corporate finance practices.
  • This is an active, concentrated strategy, designed to generate outsized returns.

Co-Invest

  • The co-invest portfolio provides exposure to new deals and follow-ons from the wider EMV Capital group portfolio and ecosystem in exciting high-growth companies.
  • These investments typically involve smaller stakes, where the fund is investing alongside other institutional VCs, large corporates and other external investors.
  • They require less active support from EMV Capital.
  • This is a strategy designed to offer the benefits of diversification and exposure to growth.

The Fund aims to invest in up to eight, equally sized investments within a 12-month period. EIS3 tax certificates are provided following each investment.

Key InformationDetails
StructureEvergreen (open all year round)
Target portfolioUp to 8 companies per portfolio within 12 months
StageSeed / Series A
SectorsDeep tech and life sciences
Minimum investment£25,000
Target Return3x Invested Capital (Gross of fees and tax benefits)
ManagerEMV Capital Partners Ltd
Third-party reviewedYes (Hardman & Co, June 2026)
Also availableDeal-by-deal direct investment alongside the fund

A selection of EMVC Evergreen EIS Fund portfolio companies

The following companies are current investments in the EMVC Evergreen EIS Fund and may not form part of the portfolio for any future subscriptions into the fund.

Future of Compute

Semi-Conductors

Sensing

AI, Autonomous Systems & Robotics

Novel Materials

SpaceTech and Satcom

Drug Discovery & Therapeutics

Medtech & Diagnostics

Tools & Technology

Digital Health

EIS Tax Reliefs

EIS investors can receive a mix of upfront and ongoing tax reliefs. For latest details see HMRC guidance here

EMV Capital does not provide tax advice; tax treatment depends on the individual circumstances of each person or entity and could also change in the future (some EIS tax benefits may require a holding period of at least 3 years). Investors should seek independent professional tax advice regarding EIS for tax relief.

Please also refer to HMRC’s latest guidance on EIS tax relief, available here

Important Notice

EIS investments are high risk and not suitable for all investors. As such, to access EIS investment information you are required to confirm that you meet one of the below criteria:

  • a certified high net worth investor;
  • a self-certified sophisticated investor;
  • a certified sophisticated investor;
  • a restricted investor.
You must select at least one option to continue. If none of these options apply to you, please contact us at investors@emvcapital.com.

Request Information


Emv Positive Logo Rgb X2
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.